The table reveals why AOD-9604 occupies a specific niche rather than competing directly with GLP-1 agonists
Do you have high cholesterol, fatty liver disease and/or abdominal fat
Take a moment now: Review your diet are you getting enough B12
These were rats having permanent major vessel occlusion, peripherally [18,19,20,21,22] and centrally [24], or with other similar noxious procedures applied [26,27,28,29,30], which severely affect endothelium function
Similarly counteracted were the consequences of electrolytes disturbances [19,55,80,105,106], neuroleptics dopamine blockade [26,51,54,55], NO system blockade [26], particular neurotoxins (inducing Parkinsons-like disturbances in mice [30] or multiple sclerosis-like disturbances in rats [31])
Results: 15.7% average weight loss (all participants)